Exchange
Last Trade
Change
Change Percent
Volume
Pricing delayed 15 minutes

Webcast 11th Annual JMP Securities Research Conference Syneron Investor Presentation May 2012 Q1 2012 Results 11th Annual Needham Healthcare Conference

Syneron Medical Ltd. (NASDAQ: ELOS) is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company’s technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring,  hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela.  Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel.  Syneron also has R&D and manufacturing operations in the US.  The company markets, services and supports its products in 86 countries.  It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide. Additional information can be found at www.syneron.com

Recent News
May 21 2012	Syneron to Host Investor Meeting on May 22, 2012
May 14 2012	Syneron's elure(TM) Advanced Skin Lightening Night Cream Wins 'Best in Black Beauty' Award From Essence Magazine
May 09 2012	Syneron Reports First Quarter 2012 Results
May 03 2012	Syneron to Present at the 11th Annual JMP Securities Research Conference

Contact IR

Feel free to contact us using the message form here.
Be sure to include your contact information if you are requesting a response.